Repligen (RGEN) Tops Q1 EPS by 7c, Revenues Beat; Raises FY19 EPS/Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. MRK
7. LVS
8. SAP
9. CSX
10. LRCX

Go back to Repligen (RGEN) Tops Q1 EPS by 7c, Revenues Beat; Raises FY19 EPS/Revenue Guidance

Repligen Reports First Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance

May 9, 2019 7:30 AM EDT

Reports first quarter revenue of $60.6 million, representing 35% year-over-year growth and 37% organic growthRaises revenue guidance to $235-$241 million for full year 2019, representing 22%-25% organic growth Enters agreement to acquire analytics leader C TechnologiesCloses follow-on offering for net proceeds of $190 million

WALTHAM, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its first quarter of 2019. Provided in this press release are financial highlights for the three-month period ended March 31, 2019, recent business... More